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Introduction
Enterovirus D68 (EV-D68) is a genotype of Enterovirus D, a 
species within the genus Enterovirus, family Picornaviridae. 
It was initially isolated in 1962 from children with bronchitis/ 
pneumonia in California, USA1. EV-D68 shares numerous 
properties with rhinoviruses, including its association with 
respiratory rather than systemic infections and, unlike other 
enterovirus A–D genotypes, its 5’ untranslated region (5’ UTR) 
end2,3. EV-D68 can be further divided into clades A, B and C and 
these can be further divided into subclades (e.g A1, A2).
Since 1962, EV-D68 has been implicated in multiple small 
outbreaks and sporadic cases of respiratory infection worldwide, 
with the associated clinical syndromes ranging in severity from 
mild to severe. However, between 2010 and 2014 EV-D68 was 
reported to the Centres of Disease Control and Prevention in the 
USA (USCDC) at much higher frequency than in previous years: 
1153 cases were confirmed, predominantly among children and 
often in a context of asthma and wheezing. A simultaneous increase 
in numbers of cases of acute flaccid paralysis was reported, and 
although an epidemiological link seems possible, a virological 
association between these events has not yet been proven4,5. 
Genomic investigation of the causative viruses of those outbreaks 
in the USA showed that the EV-D68 belonged to the subclade B14. 
Increased detections of EV-D68 were also reported in both 
children and adults from Europe and the Asia-Pacific region during 
the 2014–2015 period6–10.
Given the emergence and potential public health threat of 
EV-D68, improving our knowledge about the geographic distribu-
tion, evolution and associated clinical phenotypes of the virus is 
essential for future intervention strategies and outbreak response. 
Here we describe the detection, associated clinical features 
and molecular characterization of EV-D68 infection, using 
respiratory and cerebrospinal fluid (CSF) samples from children 
in central and southern Viet Nam between 2009 and 2015.
Methods
Clinical samples
Clinical samples were selected from three different studies previ-
ously conducted in Viet Nam. The first cohort involved children 
under two years of age with lower respiratory tract infections 
admitted to two large paediatric hospitals (Children’s Hospital 
1 and 2, Ho Chi Minh City) between 2009 and 2010 [n=632, 
median age: 7 months, interquartile range (IQR): 4 – 12]11. The 
second cohort involved children with respiratory infections visit-
ing the outpatient department of Children’s Hospital 1 between 
2009 and 2010 (n=563; median age: 1.96 years, IQR: 
1.05 – 3.18)12. The third cohort involved adults and children 
hospitalised with respiratory or central nervous system infec-
tions, admitted to five major hospitals in central and southern 
Viet Nam between 2013 and 201613, with respiratory sam-
ples (n= 3791, median age: 2 years, IQR: 1 – 4) and CSF 
samples (n= 877, median age: 17 years, IQR: 5 – 44) being 
taken. The five hospitals in Viet Nam included: i) Dong Thap 
General Hospital, Dong Thap province, ii) Hue Central Hospital, 
Hue City, iii) Dak Lak General Hospital, Ban Me Thuot City, 
iv) Khanh Hoa General Hospital, Nha Trang City, and v) Hospital 
for Tropical Diseases, Ho Chi Minh City.
Ethics
All studies were approved by the corresponding institutional 
review board of the local hospitals in Viet Nam where patients 
were enrolled: 
(i) Children Hospital 1, Ho Chi Minh City (approval 
numbers 430BVNĐ and 146/BVNĐ1-KHKT);
(ii) Hue Central Hospital, Hue City (77/25/05/12);
(iii) Dak Lak General Hospital, Ban Me Thuot City 
(489/BVT-KHTH);
(iv) Khanh Hoa General Hospital, Nha Trang City 
(356/BVĐKT);
            Amendments from Version 1
1. Method: Enterovirus D68 detection and whole genome 
sequencing:
- deleted reference (14) and replaced references15 after  
“....D68 viral specific PCR” 
- changed from “EV-D68 real time specific reverse-transcriptase 
PCR was carried out as previously described” to “EV-D68 real 
time ........(RT-PCR) was performed using D68 AN887 primers, D68 
AN890 probe and SuperScript III One-Step RT-PCR system with 
Platinum Taq (Invitrogen, Carlsbad, CA, USA). PCR amplification 
was carried out as described in the original publication15. In brief, 
in a total reaction volume of 20 μl, the PCR mixture consisted of 
5 μl of template RNA, 0.6 μM of primers D68 AN887 and 0.8 μM 
probe D68 AN890, 10 μl of Platinum PCR supermix (Invitrogen) 
and 0.4ul enzyme SuperScript III One-Step RT-PCR. The thermal 
cycling condition consisted of 1 cycle of 50°C for 30 min, 1 cycle of 
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min and 72°C for 10 sec. All RT-PCR reactions were performed in 
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- Deleted “Table 2”
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(v) Hospital for Tropical Diseases, Ho Chi Minh City 
(136/BVBNĐ – KH);
(vi) Children Hospital 2, Ho Chi Minh City,
(vii) Dong Thap General Hospital, Dong Thap province 
(approval number not available; signed date: 5/6/12.
The study was also approved by the Oxford Tropical Research 
Ethics Committee (31-08, 44-08 and 15-12).
Written informed consent was obtained from either the participant, 
or the participant’s parent or legal guardian.
Enterovirus D68 detection and whole genome sequencing
From the above described cohorts, archived respiratory samples 
and CSF were screened using a 5’ UTR PCR14, those that were 
enterovirus or rhinovirus PCR positive were selected for further 
testing by EV-D68 viral specific PCR15. EV-D68 real time specific 
reverse-transcriptase PCR (RT-PCR) was performed using D68 
AN887 primers, D68 AN890 probe and SuperScrip III One-
Step RT-PCR system with Platinum Taq (Invitrogen, Carlsbad, 
CA, USA). PCR amplification was carried out as described in the 
original publication15. In brief, in a total reaction volume of 20 μl, 
the PCR mixture consisted of 5 μl of template RNA, 0.6 μM of 
primers D68 AN887 and 0.8 μM probe D68 AN890, 10 μl of 
Platinum PCR supermix (Invitrogen) and 0.4 μl enzyme 
SuperScript III One-Step RT-PCR. The thermal cycling condi-
tion consisted of 1 cycle of 50°C for 30 min, 1 cycle of 95°C for 
2 min followed by 45 cycles of 95°C for 15sec, 55°C for 1 min 
and 72°C for 10sec. All RT-PCR reactions were performed in 
a LightCycler480 II (Roche Diagnostics, Mannheim, Germany).
EV-D68 positive specimens with a Ct-value of 32 or less were 
whole-genome sequenced using an in-house non-ribosomal ran-
dom PCR and MiSeq based approach16,17. All the experiments 
were carried out as previously described17. In short, extracted viral 
nucleic acids from nuclease-treated clinical samples were ran-
domly amplified using non-ribosomal random PCR. The result-
ing PCR products were quantified by QIAquick PCR purification 
kit (QIAgen GmbH, Hilden, Germany) and measured by Qubit 
dsDNA HS kit (Invitrogen). One nanogram of the purified DNA 
was then subjected to library preparation using the Nextera XT 
DNA sample preparation kit (Illumina, San Diego, CA, USA), 
each sample was allocated to a barcode sequence using the 
Nextera XT Index Kit (Illumina). Sequencing of the prepared library 
was carried out using the MiSeq reagent kit V3 in an Illumina 
Miseq platform (Illumina). A total of 96 samples were sequenced 
in a single run.
Sequence analysis
The generated sequencing data from Illumina MiSeq was first 
subjected to a primer removing step using standard parameters 
available in Geneious software version 8.1.5 (Biomatters, Ltd, 
Auckland, New Zealand)17,18. A reference based mapping approach 
was then employed to assemble the viral genomes, followed by 
manual editing of the obtained consensuses using Geneious. 
Samples where the full VP1 regions or whole genomes were 
successfully sequenced proceeded to recombination detection and 
phylogenetic analysis.
Recombination detection and phylogenetic analysis
All sequence alignment was carried out using MUSCLE, available 
in Geneious (Biomatters).
Recombination was inferred using a combination of methods 
(Chimera, GENECONV, Maxchi, Bootscan and Siscan) within 
RDP4 (Recombination Detection Program, version 4)19, with 
recombination supported if more than three methods showed sig-
nificant values. The recombination event was then confirmed by 
constructing a neighbor-joining tree using the group D enterovirus 
sequences. Identified recombined samples were removed from 
further phylogenetic analysis.
The origin, evolution rate and divergence time of EV-D68 were 
estimated by using representatives of VP1 sequences (n=124) and 
whole genome sequences (n=58), downloaded from GenBank 
(Supplementary Table 1 and Supplementary Table 2) alongside the 
Vietnamese sequences recovered in the present study. All analyses 
were carried out in BEAST version 1.8.320 using the General Time 
Reversible (GTR) with gamma 4 nucleotide substitution model and 
the strict molecular clock model and support for individual nodes 
was assessed using a bootstrap produce (1000 replicates). The 
molecular model was selected using Bayes factor. The Bayesian 
MCMC chain lengths were 100 million generations with sampling 
every 1000 generations.
Sequence accession numbers
The sequences of EV-D68 obtained in this study were submitted to 
NCBI under accession numbers MF045413–MF045423.
Results
Of a total 5863 samples (4986 respiratory samples and 877 CSF), 
639 (624 respiratory, 15 CSF) were positive for enterovirus or rhi-
novirus by PCR on initial screening. EV-D68 was subsequently 
detected in 21 of 624 (3.4%) of enterovirus/ rhinovirus posi-
tive respiratory samples, while no CSF samples were positive for 
EV-D68. Overall, EV-D68 was detected in 0.4% of 5863 tested 
samples, and 3.3% of 639 enterovirus/ rhinovirus positive 
respiratory/CSF samples. The earlier EV-D68 PCR positive 
sample was collected on the 4th December 2009.
Demographics and clinical features
Table 1 briefly summarises the demographics, presenting features 
and outcomes for all 21 EV-D68 PCR positive patients. All 21 
patients in whom EV-D68 was detected were aged 2 years or less, 
with a median age of 17 months at time of presentation. Three were 
admitted to the outpatient department of Children’s Hospital 1 (the 
second cohort), and the remaining 18 were inpatients enrolled into 
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Table 1. Demographics, clinical features and outcome for 21 
patients with EV-D68 PCR positive respiratory specimens. 
Categorical data were presented as n (%). Continuous variables 















   Neutrophils % total 57.3 (37.8-64.9)
   Lymphocytes % total 30.45 (22.5-43)
   Eosinophils % total 0.25 (0.2-1.9)
Platelets 347 (316-377)
Discharge outcome*
   Complete recovery 16 (76.2)
   Residual symptoms 5 (23.8)
   Death 0 (0)
the first and the third cohorts. One patient had a pre-existing neu-
rological comorbidity; the remaining 20 children were healthy at 
baseline.
All 21 patients presented with an acute respiratory illness of short 
duration (median onset 2 days prior to admission), and the median 
temperature at presentation was 38°C (range: 37.5°C – 38.4°C) 
(Table 1). No patient required admission to intensive care. All of 
the patients survived their infection, and 16 (76%) had recovered 
completely at the time of discharge. The nature of the residual 
symptoms in the remaining 5 patients was not available. There 
were no reported cases of acute flaccid paralysis in this case 
series.
Whole genome sequencing
In total, 15 samples were processed for whole genome sequenc-
ing; of these, 9 samples gave genome coverage of over 89%, with 
the uncovered sections being mainly confined to the 5’ end of the 
genome. Two additional samples gave complete coverage of the 
VP1 region.
Recombination detection
One recombination event was detected, in sample EVD68-VN5, 
with the recombination being intra sub-clade, within B1 
(Figure 1). The recombination event occurred between nucleotide 
3500 and 6300, with the sequence assembly depth remaining at 
about 1000 across the whole genome and phylogenetic tree, with 
a change in topological position within the B1 clade supported by 
the recombination event (Figure 1C). Sample EVD68-VN5 was 
therefore removed from subsequent phylogenetic inference.
Phylogenetic analysis and evolutionary rate of EV-D68
9 out of 10 Vietnamese EV-D68 VP1 sequences fell in the B1 clade 
(Figure 2), and the remaining sequence was identified within the A2 
clade. In all cases, the Vietnamese sequences clustered with Asian 
viruses. Whilst the Vietnamese viruses were not monophyletic, 
seven of the B1 sequences had other Vietnamese sequences as 
their closest relatives. Phylogenetic analysis also suggests that the 
analysis was carried out at whole genome level (Figure 3), with the 
exception that a single sequence from the A2 clade was introduced 
earlier (2006).
Page 5 of 17
Wellcome Open Research 2018, 2:41 Last updated: 11 MAY 2018
Figure 1. Recombination analysis of EVD68-VN9. (A) Similarity plot analysis of EVD68-VN5 against the two heterogenic parents, EVD68-
VN3 (blue) and EVD68-VN7 (purple). The x-axis indicates the number of nucleotides along the alignment, the y-axis indicates percentage 
similarity. (B) Bootscan plot analysis supporting for the recombination event of EVD68-VN5 detected by similarity plot analysis in (A). The 
y-axis indicates the percentage of bootstrap values. (C) Phylogenetic analyses of nonrecombinant fragments of representatives of clade B1; 
the putative recombinant strain is in red.
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Figure 2. MCC tree from Bayesian timescale phylogenetic analysis based on complete VP1 nucleotide sequence (927nt) of EV-D68 
including Vietnamese strains obtained from this study (dark blue) and global representatives retrieved from GenBank.
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Figure 3. MCC tree from Bayesian timescale phylogenetic analysis based on complete genomes of EV-D68 including Vietnamese 
strains obtained from this study (dark blue) and global representatives retrieved from GenBank.
The rate of evolution of EV-D68 was calculated from the VP1 
data as 5.12E-3 substitutions/site/year. Bayesian analysis suggests 
that the EV-D68 origin lies in late 1960, and the common 
ancestor of the lineages under-investigation arose in 1994.
Discussion
Herein we have described for the first time the clinical presentation 
and phylogenetic characterization of EV-D68 in Viet Nam for the 
period 2009 to 2015.
Of 639 patients whose nasopharyngeal or CSF sample tested posi-
tive for enterovirus or rhinovirus on multiplex PCR, 21 (3.2%) 
respiratory samples were found to be positive for EV-D68 on 
specific RT-PCR. Overall, of 4986 respiratory samples screened, 
0.4% were positive for EV-D68. This indicates that EV-D68 has 
been circulating at low levels in Viet Nam between 2009 and 2015; 
however, it does not represent a major contribution to the burden 
of acute respiratory illness in the region, in line with findings by 
Nguyen et al. that show enteroviruses only account for 5% of 
respiratory illness in Viet Nam21. The EV-D68 specific RT-PCR 
used in the present study has been shown to have a sensitivity and 
specificity of 98.6% and 97.5% respectively15, however evaluation 
of assay performance has only taken place in the United States. 
Therefore, the assay sensitivity and specificity on South-Easrt 
Asian clades of EV-D68 remain unknown and thus some may 
have been missed in our cohort, although as originally designed, 
the assay should be able to detect all EV-D68 strains from 
Asia, Europe and the US.
All of 21 EV-D68 positive patients were aged less than 2 years, 
presented with a respiratory illness of short duration and none 
needed admission to intensive care units. This is consistent with 
the findings of Xiang et al.22 who reported that EV-D68 infection 
predominantly caused non-severe respiratory illness in children 
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in China between 2006 and 2014, but differs from reports from 
Thailand and Cambodia, where EV-D68 positive patients were 
mostly older children and adults, respectively23,24. It should be 
noted, however, that the majority of our patients were children, 
which may explain the difference. Likewise, it has recently been 
reported in the Netherlands that EV-D68 was associated with 
severe respiratory infection in young children, however most 
of these patients had pulmonary co-morbidity at baseline25.
Our phylogenetic analysis puts the identified Vietnamese EV-D68 
in a global context and shows that the EV-D68 viruses circulat-
ing in Viet Nam belong to subclade B1, which includes EV-D68 
viruses sampled across various continents including Asia, Europe 
and America. Our Vietnamese viruses are, however, most closely 
related to other Asian strains, and cluster separately within 
subgroup B1 from those which have been associated with epidemic 
outbreaks and implicated in acute flaccid paralysis in the USA in 
children with a median age of 8 years4. It should however be noted 
that to date there has been no definitive link between specific 
EV-D68 strains and clinical phenotypes. Likewise, the causative 
role of EV-D68 in acute flaccid paralysis remains unproven.
Interestingly, we report herein a recombination event within our 
EV-D68 whole genome data set. This represents the second 
reported recombination within EV-D6826, although recombination 
is a common phenomenon of enterovirus evolution.
The non-monophyletic clustering pattern suggests that EV-D68 
was introduced in Viet Nam multiple times, while the low- 
level clustering suggests some persistence within Viet Nam, 
with no outbreak reported until now. Our data agrees with other 
published estimations of the origin and evolution rate of 
EV-D6823,27.
Conclusion
We have demonstrated that EV-D68 has been circulating at 
low levels in Viet Nam in the period of 2009 to 2015, and is 
associated with a moderate acute respiratory infection in healthy 
children in our cohorts. EV-D68 in Viet Nam is most closely 
related to other circulating Asian strains, and clusters separately 
from those implicated to be associated with acute flaccid paralysis 
in the USA and Europe.
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